Osteosarcoma (OS) is a malignant bone tumor with a poor prognosis. Metastasis reduces the long-term survival of OS patients, with a five-year survival rate of less than 20%. Delineating the underlying ...

6-Year-Old Had What Looked Like a Bug Bite. 1 Year Later, She Was Gone from Cancer (Exclusive) Noelle Franklin was diagnosed with Osteosarcoma, a rare form of bone cancer, in May 2024 ...

CD70 expression increased cytotoxicity of CD70 CAR NK cells against osteosarcoma; however, upregulation of CD70 had no effect on cytotoxicity.

Positive results from clinical trials of an immune therapy in dogs with bone cancer have been used to fast-track the development of the drug to treat children with the same cancer. It highlights ...

CEO Paul Romness highlighted that canine osteosarcoma affects over 40,000 dogs annually in the U.S., noting that the subsidiary was created to capitalize on a clear market opportunity to improve ...

Conventional osteosarcoma commonly contains varying amounts of cartilaginous and/or fibroblastic neoplastic components. Per the predominant matrix, this subtype is classified as osteoblastic (76-80%), ...

(RTTNews) - OS Therapies Inc. (OSTX) Thursday announced positive data for OST-HER2 in combination with palliative radiation in dogs with unresected appendicular osteosarcoma.

The data opens the potential for OST-HER2 to be used in frontline therapy in human osteosarcoma prior to initiation of chemotherapy, and potentially reduce the need for chemotherapy altogether ...

Davis Randle's teammates said the strength he's showed throughout the struggle of battling cancer has motivated them all season.

GSK’s B7-H3-targeted antibody-drug conjugate, GSK’227, receives US FDA Breakthrough Therapy designation in late-line relapsed or refractory osteosarcoma. News release.